ZYNERBA PHARMACEUTICALS INC (ZYNE)
Institutional ownership reported to the SEC as of Q1 2024, across 21 quarters.
1
Reporting holders
$16.2K
Reported value
0.0%
Held as options
-37
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| B. Riley Wealth Advisors, Inc. | $16.2K | 12,732 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2024 | 1 | $16.2K | 12,732 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 38 | $13.2M | 10,322,761 | 18 | 3 | 9 | 0.5% |
| Q2 2023 | 37 | $1.4M | 4,407,374 | 4 | 4 | 11 | 0.7% |
| Q1 2023 | 35 | $2.2M | 5,089,712 | 5 | 3 | 9 | 0.3% |
| Q4 2022 | 38 | $3.2M | 5,913,912 | 11 | 6 | 8 | 1.0% |
| Q3 2022 | 50 | $8.1M | 10,912,766 | 9 | 10 | 14 | 1.0% |
| Q2 2022 | 44 | $12.7M | 10,977,093 | 7 | 11 | 13 | 1.2% |
| Q1 2022 | 49 | $27.8M | 13,174,484 | 8 | 16 | 13 | 1.2% |
| Q4 2021 | 53 | $41.2M | 13,633,413 | 6 | 16 | 17 | 4.4% |
| Q3 2021 | 54 | $60.5M | 13,519,711 | 8 | 17 | 15 | 5.6% |
| Q2 2021 | 66 | $84.4M | 14,646,425 | 17 | 24 | 16 | 7.5% |
| Q1 2021 | 61 | $49.6M | 9,055,384 | 17 | 18 | 11 | 15.1% |
| Q4 2020 | 57 | $26.3M | 6,684,243 | 8 | 19 | 12 | 16.0% |
| Q3 2020 | 62 | $20.7M | 5,455,650 | 11 | 12 | 27 | 12.7% |
| Q2 2020 | 77 | $44.1M | 7,601,080 | 31 | 17 | 20 | 41.9% |
| Q1 2020 | 74 | $38.5M | 9,214,310 | 10 | 20 | 21 | 8.4% |
| Q4 2019 | 80 | $76.3M | 11,019,009 | 10 | 28 | 16 | 12.8% |
| Q3 2019 | 86 | $91.7M | 10,460,853 | 18 | 35 | 13 | 13.7% |
| Q2 2019 | 77 | $175.4M | 8,620,692 | 36 | 22 | 7 | 33.5% |
| Q1 2019 | 59 | $15.7M | 2,304,940 | 12 | 16 | 17 | 20.7% |
| Q4 2018 | 59 | $9.5M | 2,810,826 | 5 | 1 | 1 | 12.5% |